|
Dubai, United Arab Emirates, February 20, 2014: A delegation headed by His Excellency Engineer Essa Al Maidoor, Director-General of the Dubai Health Authority(DHA) recently left for France, Germany and Netherlands to discuss mutual cooperation with a number of leading institutions in the field of healthcare.
Al Maidoor stressed on the importance of this tour that is in line with the DHA's efforts to establish partnership with leading medical institutions and organizations in the world.
He said the purpose of the tour is two-fold; firstly the DHA aims to meet with leading academic institutions in these countries and collaborate with them to provide medical staff in Dubai with excellent educational opportunities; secondly the Authority aims to meet with world renowned medical institutions to collaborate in specific areas of healthcare.
Such collaborative initiatives will not only benefit patients but also help provide an impetus to the Dubai Medical Tourism initiative.
DHA and France: Collaboration in futuristic fields like genetic mapping.
Al Maidoor said that Dubai Health Authority and the Ministry of Health in France have been collaborating within specific areas of healthcare over the past few months and during this tour several agreements will be signed specifically outlining areas of cooperation.
He said the collaboration looks into certain areas of interest including identification and management of infectious diseases, oncology, genetic mapping etc.
Al Maidoor highlighted that genetic mapping is a futuristic field and is essential as one can greatly identify the chance of a couple having a child with a genetic disorder such as Thalassemia. Gene mapping can be effectively used in premarital screening as well.
The DHA delegation will visit various healthcare institutions and medical universities in France such as the Institute of Gustave Roussy of Oncology which was established in 1926 and Necker Hospital which was established in 1778 and is historically the first paediatric hospital in the world.
He said the UAE is keen to collaborate with healthcare institutions from across the globe and that the key parameters for the DHA are quality, innovation and most importantly patient-centered care.
DHA and Netherlands: Collaboration in the field of diagnostics.
Al Maidoor discussed the delegation's plans to visit Netherlands where they will meet with several high ranking officials from Philips to discuss ways to collaborate for the proposed Dubai Diagnostics Centre.
Philips is a Dutch diversified technology company headquartered in Amsterdam with primary divisions focused in the areas of Healthcare, Consumer Lifestyle and Lighting.
The delegation will also visit the company's research and training facilities.
Al Maidoor said the Dubai Diagnostic Centre will be built by the DHA using the latest technology and international standards and will be linked to 5,000 diagnostic centres globally.
The centre will offer outstanding services that are intended to help healthcare practitioners diagnose patients quickly and accurately so as to provide the necessary treatment.
DHA and Germany: Collaborate in the field of Ortho-Trauma specialization.
Al Maidoor also mentioned that during the delegation's tour in Germany, they will hold meetings with the Berlin Medical Board to implement an Ortho-Trauma Specialization Program. The delegation will also visit a number of medical centers and meet with officials from Siemens, in addition to visiting the DHA treatment offices in Berlin, Munich, and Bonn.
The DHA delegation headed by Al Maidoor includes Eng. Ali Al Mazyood, Dr. Khaldoon Nabhan, Dr. Alya Al Mazrouei, Dr. Abdulrahman Al Jassmi, Dr. Mansoor Nazari, Dr Philippe Macaire Dr. Mona Al Mazrouei, Mr. Ahmad Al Umari, Abdulrahman Al Owghani, Dr. Zeyad Alrais, Dr. Jamal AlMulla, Dr. Bilal El Yafawi, and Mahmoud Yousef.
| 
RSS Feed 
